Literature DB >> 9362398

Predictive factors of restenosis after coronary stent placement.

A Kastrati1, A Schömig, S Elezi, H Schühlen, J Dirschinger, M Hadamitzky, A Wehinger, J Hausleiter, H Walter, F J Neumann.   

Abstract

OBJECTIVES: The objective of this study was to identify clinical, lesional and procedural factors that can predict restenosis after coronary stent placement.
BACKGROUND: Coronary stent placement reduces the restenosis rate compared with that after percutaneous transluminal coronary angioplasty (PTCA). However, restenosis remains an unresolved issue, and identification of its predictive factors may allow further insight into the underlying process.
METHODS: All patients with successful coronary stent placement were eligible for this study unless they had had a major adverse cardiac event during the 1st 30 days after the procedure. Of the 1,349 eligible patients (1,753 lesions), follow-up angiography at 6 months was performed in 80.4% (1,084 patients, 1,399 lesions). Demographic, clinical, lesional and procedural data were prospectively recorded and analyzed for any predictive power for the occurrence of late restenosis after stenting. Restenosis was evaluated by using three outcomes at follow-up: binary restenosis as a diameter stenosis > or =50%, late lumen loss as lumen diameter reduction and target lesion revascularization (TLR) as any repeat PTCA or coronary artery bypass surgery involving the stented lesion.
RESULTS: Multivariate analysis demonstrated that diabetes mellitus, placement of multiple stents and minimal lumen diameter (MLD) immediately after stenting were the strongest predictors of restenosis. Diabetes increased the risk of binary restenosis with an odds ratio (OR) [95% confidence interval] of 1.86 [1.56 to 2.16] and the risk of TLR with an OR of 1.45 [1.11 to 1.80]. Multiple stents increased the risk of binary restenosis with an OR of 1.81 [1.55 to 2.06] and that of TLR with an OR of 1.94 [1.66 to 2.22]. An MLD <3 mm at the end of the procedure augmented the risk of binary restenosis with an OR of 1.81 [1.55 to 2.06] and that of TLR with an OR of 2.05 [1.77 to 2.34]. Classification and regression tree analysis demonstrated that the incidence of restenosis may be as low as 16% for a lesion without any of these risk factors and as high as 59% for a lesion with a combination of these risk factors.
CONCLUSIONS: Diabetes, multiple stents and smaller final MLD are strong predictors of restenosis after coronary stent placement. Achieving an optimal result with a minimal number of stents during the procedure may significantly reduce this risk even in patients with adverse clinical characteristics such as diabetes.

Entities:  

Mesh:

Year:  1997        PMID: 9362398     DOI: 10.1016/s0735-1097(97)00334-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  74 in total

Review 1.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 2.  Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.

Authors:  T M Schiele
Journal:  Z Kardiol       Date:  2005-11

3.  Are drug eluting stents really worth the money?

Authors:  M Thomas
Journal:  Heart       Date:  2005-06-06       Impact factor: 5.994

Review 4.  In stent restenosis: bane of the stent era.

Authors:  A K Mitra; D K Agrawal
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

5.  Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-endothelialisation in a porcine model.

Authors:  R Waksman; I M Leitch; J Roessler; H Yazdi; R Seabron; F Tio; R W Scott; R I Grove; S Rychnovsky; B Robinson; R Pakala; E Cheneau
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

6.  The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry.

Authors:  Ralf Zahn; C W Hamm; S Schneider; U Zeymer; G Richardt; M Kelm; B Levenson; T Bonzel; U Tebbe; G Sabin; C A Nienaber; Thomas Pfannebecker; J Senges
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

7.  Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry.

Authors:  Helge Möllmann; Albrecht Elsässer; Holger Nef; Steffen Schneider; Christoph A Nienaber; Gert Richardt; Michael Weber; Malte Kelm; Benny Levenson; Tassilo Bonzel; Ulrich Tebbe; Georg Sabin; Thomas Pfannebecker; Jochen Senges; Christian W Hamm
Journal:  Clin Res Cardiol       Date:  2008-03-03       Impact factor: 5.460

8.  ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention.

Authors:  Svati H Shah; Elizabeth R Hauser; David Crosslin; Liyong Wang; Carol Haynes; Jessica Connelly; Sarah Nelson; Jessica Johnson; Shera Gadson; Charlotte L Nelson; David Seo; Simon Gregory; William E Kraus; Christopher B Granger; Pascal Goldschmidt-Clermont; L Kristin Newby
Journal:  Atherosclerosis       Date:  2008-02-12       Impact factor: 5.162

9.  Sirolimus-eluting stent treatment for isolated proximal left anterior descending artery stenoses. Results from the prospective multi-center German Cypher Registry.

Authors:  A A Khattab; C W Hamm; J Senges; R Toelg; V Geist; T Bonzel; M Kelm; B Levenson; C A Nienaber; G Sabin; S Schneider; U Tebbe; G Richardt
Journal:  Z Kardiol       Date:  2005-03

Review 10.  Pathology of atherosclerosis and stenting.

Authors:  Frank D Kolodgie; Gaku Nakazawa; Giuseppe Sangiorgi; Elena Ladich; Allen P Burke; Renu Virmani
Journal:  Neuroimaging Clin N Am       Date:  2007-08       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.